Author: Irene

PHILADELPHIA, PA, Apr 3, 2026 - (ACN Newswire via SeaPRwire.com) - Datavault AI Inc. ("Datavault AI" or the "Company") (NASDAQ:DVLT), a leader in data monetization, credentialing, digital engagement, and real-world asset ("RWA") tokenization technologies, today announced that CEO Nathaniel (Nate) T. Bradley will present and exhibit the Company's DataValue®, DataScore®, Data Vault Bank® AI Agent, and patented Information Data Exchange® technologies at XRP Tokyo 2026 on April 7, 2026, at Happo-en in Tokyo, Japan.Bradley's presentation, "Data-Driven RWA Tokenization: Unlocking Japan's Trillion-Yen Opportunity on the XRP Ledger," will demonstrate how Datavault AI's platforms support secure, AI-powered tokenization of real estate, commodities, and other high-value assets in Japan's regulation-friendly market.Japan has emerged as Asia's leading real-world asset tokenization market, with institutional platforms such as Progmat (MUFG-backed) managing approximately ¥440 billion (~$2.8 billion USD) in tokenized assets, primarily real estate and corporate bonds. Broader public STO (Security Token Offering) activity has reached the $1.3-2 billion+ range, with the sector projected to exceed ¥1 trillion (~$6-7 billion) by the end of 2026. Recent momentum includes MUFG's March 2026 launch of its ¥22.4 billion (~$142 million) Osaka Dojimahama Tower real estate security token, one of the largest single issuances to date."Japan's institutional adoption of tokenized real-world assets, combined with clear regulatory frameworks, creates exceptional opportunities for scalable licensing and customer partnerships," said Nathaniel Bradley, CEO of Datavault AI. "At XRP Tokyo, we'll demonstrate how our AI-powered data valuation and tokenization infrastructure can help Japanese institutions unlock liquidity in real estate, commodities, and other high-value assets. We're focused on building long-term commercial relationships across the APAC region that translate into meaningful revenue opportunities for Datavault AI."Hosted by XRPL Japan as part of the TEAMZ Web3/AI Summit 2026, XRP Tokyo 2026 brings together developers, enterprises, investors, and institutions to explore real-world blockchain applications, including tokenization, payments, and digital asset infrastructure.Datavault AI's participation builds on its growing momentum in RWA tokenization and reflects its strategic focus on APAC market expansion and international customer development.About Datavault AI Inc.Datavault AI TM (NASDAQ:DVLT) is leading the way in AI-driven data experiences, valuation, and monetization of assets in the Web 3.0 environment. The Company's cloud-based platform provides comprehensive solutions with a collaborative focus in its Acoustic Sciences and Data Sciences divisions.Datavault AI's Acoustic Sciences division features WiSA®, ADIO®, and Sumerian® patented technologies and industry-first foundational spatial and multichannel wireless, high-definition sound transmission technologies with intellectual property covering audio timing, synchronization, and multi-channel interference cancellation. The Data Science Division leverages the power of Web 3.0 and high-performance computing to provide solutions for experiential data perception, valuation, and secure monetization.Datavault AI's platform serves multiple industries, including high-performance computing software licensing for sports & entertainment, events & venues, biotech, education, fintech, real estate, healthcare, energy, and more. The Information Data Exchange® enables Digital Twins and the licensing of name, image, and likeness by securely attaching physical real-world objects to immutable metadata, fostering responsible AI with integrity. The Company's technology suite is fully customizable and offers AI- and machine-learning-based automation, third-party integration, detailed analytics and data, marketing automation, and advertising monitoring.The Company is headquartered in Philadelphia, PA. Learn more about Datavault AI at https://datavaultsite.comAbout XRP Tokyo 2026XRP Tokyo 2026 is Japan's premier XRP-focused conference, taking place April 7, 2026, at Happo-en, Tokyo. Hosted by XRPL Japan, the event showcases the XRP Ledger's role in institutional adoption and real-world blockchain innovation. More information: xrp-tokyo.io.Market Data SourcesJapan real-world asset tokenization market data: "Progmat Pivots to Public Chain: Migrates 440 Billion Yen in Security Token Assets to Avalanche," FinTech Observer, February 26, 2026 (https://www.fintechobserver.com/progmat-pivots-to-public-chain-migrates-440-billion-yen-in-security-token-assets-to-avalanche/); "MUFG Enters $1.3 Billion Japan Security Token Market," BeInCrypto, October 10, 2025 (https://beincrypto.com/mufg-enters-1-3-billion-japan-security-token-market/); "BOOSTRY Publishes Japan Security Token Market Report (FY2024)," Nomura Holdings, April 2, 2025 (https://www.nomuraholdings.com/en/news/nr/news202504022.html); "Progmat Migrates $2B+ of its Tokenized Securities to Avalanche," Avax.network, February 25, 2026 (https://www.avax.network/about/blog/progmat-migrates-2b-tokenized-securities-to-avalanche); "MUFG launches first own brand real estate security token for $142 million," Ledger Insights, March 2026 (https://www.ledgerinsights.com/mufg-launches-first-own-brand-real-estate-security-token-for-142-million/).Forward-Looking StatementsThis press release contains "forward-looking statements" (within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and other securities laws) about Datavault AI Inc. ("Datavault AI," the "Company," "us," "our," or "we") and our industry that involve risks and uncertainties. In some cases, you can identify forward-looking statements because they contain words, such as "may," "might," "will," "shall," "should," "expects," "plans," "anticipates," "could," "intends," "target," "projects," "contemplates," "believes," "estimates," "predicts," "potential," "goal," "objective," "seeks," "likely" or "continue" or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. The absence of these words does not mean that a statement is not forward-looking. Such forward-looking statements, including, but not limited to, statements regarding future events, the creation of opportunities for scalable licensing and customer partnerships as a result of Japan's institutional adoption of tokenized RWAs, and how the Company's AI-powered data valuation and tokenization infrastructure can help Japanese institutions unlock liquidity in real estate, commodities and other high-value assets, and expected operational, technical, and commercial outcomes of the Company's commercial strategy, and the projected direction and market impacts of regulatory changes with respect to digital assets, are necessarily based upon estimates and assumptions that, while considered reasonable by the Company and its management, are inherently uncertain.Readers are cautioned not to place undue reliance on these and other forward-looking statements contained herein.Actual results may differ materially from those indicated by these forward-looking statements as a result of various risks and uncertainties including, but not limited to, the following: the Company's ability to create opportunities for scalable licensing and customer partnerships as a result of Japan's institutional adoption of tokenized RWAs; the Company's ability to help Japanese institutions unlock liquidity in real estate, commodities and other high-value assets through its AI-powered data valuation and tokenization infrastructure; changes in market demand for Datavault AI's services and products; changes in economic, market, or regulatory conditions; risks relating to evolving regulatory frameworks applicable to tokenized assets; risks associated with technological development and integration; and other risks and uncertainties as more fully described in Datavault AI's filings with the SEC, including its Annual Report on Form 10-K for the year ended December 31, 2025 and other filings that Datavault AI makes from time to time with the SEC, which are available on the SEC's website at www.sec.gov, and could cause actual results to vary from expectations.The forward-looking statements made in this press release relate only to events as of the date on which the statements are made. Datavault AI undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law.Datavault AI may not actually achieve the plans, intentions, or expectations disclosed in its forward-looking statements, and you should not place undue reliance on such forward-looking statements. Datavault AI's forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures, or investments it may make.Industry and Market DataWithin this press release, we reference information and statistics regarding the market for our products. We have obtained some of this information and statistics from various independent third-party sources, including independent industry publications, reports by market research firms and other independent sources. Some data and other information contained in this press release are also based on management's estimates and calculations, which are derived from our review and interpretation of internal surveys and independent sources. Data regarding the industries in which we compete and our market position and market share within these industries are inherently imprecise and are subject to significant business, economic and competitive uncertainties beyond our control, but we believe they generally indicate size, position and market share within this industry. While we believe such information is reliable, we have not independently verified any third-party information. While we believe our internal company research and estimates are reliable, such research and estimates have not been verified by any independent source. In addition, assumptions and estimates of our and our industries' future performance are necessarily subject to a high degree of uncertainty and risk due to a variety of factors. These and other factors could cause our future performance to differ materially from our assumptions and estimates. As a result, you should be aware that market, ranking and other similar industry data included in this press release, and estimates and beliefs based on that data, may not be reliable.Media ContactAlan WallaceHead of Public Relationsmarketing@dvlt.ai+1.267.817.7251Investor ContactEdward BargerVP, Investor Relationsebarger@dvlt.aiFor more information on Datavault AI's RWA solutions or to schedule an interview with Nathaniel Bradley, contact the press team above.SOURCE: Datavault AI Inc Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

West Palm Beach, FL, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - U.S. Polo Assn., the official sports brand of the United States Polo Association (USPA), proudly supported the Division I National Intercollegiate Championship (NIC), held March 19-22, 2026, near Dallas, Texas, at the Prestonwood Polo & Country Club. As the highest level of collegiate polo in the United States, the NIC brings together the nation's top student-athletes to compete for national titles.2026 Division I Women's National Intercollegiate Champions, University of South Carolina - Aiken Polo Team Winifred Branscum, Madison Jordan, and Brianna Jordan; 2026 Division I Men's National Intercollegiate Champions, University of North Texas Polo Team Alec Felhaber, Niklaus Felhaber, Johann Felhaber, Mosiah Gravesande, Sebastian Celis GuerreroPhoto Credit: @oanaphotoAs a proud supporter of the USPA's Intercollegiate/Interscholastic (I/I) Program, U.S. Polo Assn. continues to invest in the next generation of polo players. For the 2026 NIC, the global sport brand provided custom event t-shirts for all participants, featuring special-edition designs honoring the 50th Anniversary of the Division I Women's NIC, along with player prizes for all finalists and exclusive U.S. Polo Assn. Champions Caps to the winning teams. On-site, the sport brand also enhanced the fan experience with cap giveaways, adding to the energy of the championship atmosphere.Division I Women's National Intercollegiate Championship at a Glance:Final Matchup: University of South Carolina - Aiken(Winifred Branscum, Brianna Jordan, Madison Jordan) vs. Texas A&M University(Josie Dorsey, Francesca Felhaber, Jordan Fikes, Alternates: Kylie Beard, Emily Coflin, Sophia DeAngelis)Date: March 22, 2026Location: Prestonwood Polo & Country Club, Oak Point, TexasFinal Score: 15 (USC-Aiken) - 6 (Texas A&M)All-Stars: Madison Jordan (USC-Aiken), Josie Dorsey (TAMU), Kelsey Bray (UVA), and Winifred Branscum (USC-Aiken)Best Playing Pony: Fiscal, played and owned by Winifred Branscum (USC-Aiken)Division I Men's National Intercollegiate Championship at a Glance:Final Matchup: University of North Texas(Alec Felhaber, Johann Felhaber, Niklaus Felhaber, Mosiah Gravesande, Alternate: Sebastian Celis Guerrero) vs. Cornell University(Benito Jarmillo, Malachi Light, Max Sponer, Alternates: Harrison Fredericks, Fin Maroney, Mihali Pinzon, Dylan Tung)Date: March 22, 2026Location: Prestonwood Polo & Country Club, Oak Point, TexasFinal Score: 15 (UNT) -13 (Cornell)All-Stars: Will Mudra (TAMU), Malachi Light (Cornell), Benito Jarmillo (Cornell), Johann Felhaber (UNT)Best Playing Pony: Zury, owned by Texas A&M UniversityU.S. Polo Assn. supports more than 30 colleges and universities and approximately 70 teams nationwide through its Collegiate Partnership Program (CPP). During its eighth consecutive year, the brand supports the next generation of polo players through jerseys, custom-performance apparel, branded equipment, financial contributions, and more. The CPP is available to all colleges and universities, with its participating teams ranging from the East to the West Coast and including small private and large public institutions, as well as Ivy League and Historically Black Colleges or Universities (HBCUs)."The Division I National Intercollegiate Championship represents the future of the sport, where dedication, teamwork, and passion for the sport of polo come together at the highest level of collegiate competition," said J. Michael Prince, President and CEO of USPA Global, the company that manages the multi-billion-dollar U.S. Polo Assn. brand. "U.S. Polo Assn. is proud to support these exceptional student-athletes and to continue investing in the next generation of players and future leaders at every level.""Congratulations to all of the participants in the Division I Women's and Men's Championships, and good luck to the Division II National Intercollegiate Championships participants next month," added Prince.The Division I Women's and Men's Finals will be featured on Global Polo's award-winning show, "Breakaway: Polo in College," and distributed across ESPN and Global Polo platforms, extending the reach of collegiate championship polo to a global audience. Check local listings for airtimes."The 2026 National Intercollegiate Championship marks the 50th Anniversary of the Division I Women's Intercollegiate Tournament, and it's inspiring to see the remarkable talent and commitment these student-athletes have shown throughout such a highly competitive and significant season," said Liz Brayboy, Chair of the USPA's Intercollegiate/Interscholastic (I/I) Committee. "With the continued support of U.S. Polo Assn., collegiate polo continues to grow and reach new audiences and sports fans, which is incredibly exciting for us, and collegiate sports overall."About U.S. Polo Assn. and USPA GlobalU.S. Polo Assn. is the official sports brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,200 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. The brand sponsors major polo events around the world, including the U.S. Open Polo Championship®, held annually at NPC in The Palm Beaches, the premier polo tournament in the United States. Historic deals with ESPN in the United States, TNT and Eurosport in Europe, and Star Sportsin India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, PGA Tour, and Formula 1, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global growth and sport content. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world. For more information, visit uspoloassnglobal.com and follow @uspoloassn.USPA Global is a subsidiary of the United States Polo Association (USPA) and manages the multi-billion-dollar sports brand, U.S. Polo Assn. USPA Global also manages the subsidiary, Global Polo, which is the worldwide leader in polo sport content. To learn more, visit globalpolo.com or Global Polo on YouTube.For Additional Information, Contact:Shannon Stilson - VP, Sports Marketing and MediaPhone +001.561.227.6994 - E-mail: sstilson@uspagl.comStacey Kovalsky - VP, Global PR and CommunicationsPhone +001.561.790.8036 - E-mail: skovalsky@uspagl.comSOURCE: U.S. Polo Assn. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

Vancouver, BC, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - Founders Metals Inc. (TSXV: FDR) (OTCQX: FDMIF) (FSE: 9DL0) ("Founders" or the "Company") announces a new high-grade gold discovery at its Antino Gold Project ("Antino" or "Project") in southeastern Suriname. The Company reports high-grade gold mineralization from surface, returning 17.22 grams per tonne (g/t) gold (Au) over 3.6 metres (m) within a broader 24.6 m interval grading 2.81 g/t Au, in the first-ever drillhole in the Antino North area (Figure 1).HighlightsFirst ever Antino North drilling delivers exceptional results from surface in the first drillhole (AN001)24.6 m of 2.81 g/t Au including 3.60 m of 17.22 g/t Au from 1.5 m down hole13.5 m of 0.44 g/t Au from 54.6 mFirst drillhole testing one of twelve gold-bearing structures identified to date at Antino NorthSurface work continues:Over 4,500 auger samples to date in 2026Total combined strike length of mapped shear zones on surface is 5.3 kmSecond Antino North drill now turning on previously undrilled kilometre-scale gold auger anomaly (Figure 2)Colin Padget, President & CEO, commented, "The Antino North area covers nearly 10,000 hectares of highly prospective geology that has never seen a drillhole - so we are thrilled to see such high-grade results from our first diamond hole into the area. Our team on the ground has so far mapped twelve parallel shear zones across and along strike of the intercepted structure, and we plan to test many of them over the current ~3,500 metre phase-one drill program. This Antino North discovery reinforces our belief that the larger Antino Project is host to a major district-scale gold system, and there remains significant exploration upside and opportunity for further discoveries with this year's exploration program."Antino North DrillingThe new discovery is hosted within a series of approximately 5- to 25-metre-wide shear zones, with geological characteristics consistent with high-grade gold mineralization documented elsewhere on the Antino Gold Project, including at Upper Antino. The reported drillhole tested the first of twelve northwest-trending parallel shears recently mapped over multiple kilometres across the Antino North area, highlighting the significant scale of the mineralizing system. The mapped shear zones are spatially coincident with a large regional-scale fold - a structural setting commonly associated with orogenic gold deposits across the Guiana Shield.Mineralization is similar in character to the shear- and vein-hosted gold mineralization at Upper Antino, comprising sheared subvertical quartz veins with late brittle deformation overprinting and a sericite-ankerite-tourmaline alteration assemblage.The Antino North concession has no record of historical diamond drilling. This discovery represents the first drill-tested gold zone within the recently acquired exploration concession, located approximately 20 kilometres southwest of the Upper Antino area - confirming the potential for new mineralized centres across the district-scale Antino land package.Table 1: Drill Hole Assay ResultsDrillholeFrom (m)To (m)Interval (m)Au (g/t)AN0011.5026.1024.602.81incl1.505.103.6017.22and54.6068.1013.500.44 *Intervals are down-hole depths. True widths of mineralization are unknown at this time based on currently available results and observations. All are diamond drill holes. Interval average grades are calculated with un-capped gold assays, as insufficient drilling has been completed to determine capping levels for higher-grade gold intercepts. Widths are calculated using a 0.10 g/t gold cut-off grade with

HONG KONG, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - Luxury new energy vehicle (NEV) enterprise Seres officially released its 2025 annual results on March 30, with several core financial indicators recording steady growth and profitability continuing to strengthen for the second consecutive year, attracting widespread market attention.The results report shows that in 2025, Seres achieved revenue of approximately RMB164.89 billion with a year-on-year increase of 13.63%, net profit attributable to shareholders of the listed company was RMB5.96 billion and R&D investment reached RMB12.51 billion, a year-on-year increase of 77.4%. The Company also announced a proposed final dividend of RMB0.8 per share (tax included), totaling approximately RMB1.9 billion in cash dividends, reflecting its commitment to rewarding shareholders.In terms of sales performance, Seres' NEV sales continued to maintain a high level. Annual sales in 2025 reached 472,269 units, representing a year-on-year increase of 10.63%. The Group's premium brand AITO recorded cumulative annual deliveries exceeding 420,000 units, making it the best-selling Chinese luxury automotive brand in the domestic market. Across the full lineup, the AITO M5, M7, M8, and M9 collectively surpassed one million cumulative deliveries. The coordinated growth in both sales and profit further strengthened the Group's overall operational resilience and risk management capabilities.In terms of R&D investment, Seres has maintained a strong commitment. In 2025, the Company’s R&D investment reached RMB12.51 billion, representing a year-on-year increase of 77.4%. Both the intensity and growth rate of R&D investment remained industry-leading, reflecting the Company’s adherence to a technology-driven strategy and laying a solid foundation for future product iteration and core competitiveness.The Group’s cash flow performance was also robust. As of December 31, 2025, net cash flow from operating activities amounted to RMB28.12 billion. Ample cash reserves enabled the Company to support high-intensity R&D and international expansion while building a stronger risk buffer and enhancing strategic flexibility.Kaiyuan Securities, Changjiang Securities, CICC, and Guotai Haitong are among the major brokerages maintaining positive ratings on Seres — Kaiyuan and Changjiang with "Buy," Guotai Haitong with "Overweight," and CICC with "Outperform" alongside a revised target price of RMB 120. All institutions are optimistic on Seres' long-term growth prospects, noting that underlying business fundamentals continue to improve with a clear and compelling growth thesis. Key catalysts include a dense Q2 model launch cycle (AITO M6 and refreshed M9/M8), accelerating overseas expansion into the Middle East and Europe, and a robotics business increasingly seen as a credible second growth curve.Overall, Seres delivered a comprehensive upgrade in its 2025 results, spanning sales volume, profit, R&D and cash flow. The Company stated that it will continue to position itself as a luxury vehicle enterprise, deepen its presence in the intelligent NEV sector, further increase investment in core technologies, enrich its high-end product portfolio, accelerate its global market expansion, and focus on improving profitability and core competitiveness, thereby supporting the continued upgrading of China’s new energy vehicle industry. For investors, this performance has undoubtedly strengthened confidence in the Company’s future growth. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - Across the landscape of global biotech companies, the appointment of a senior executive often serves as a "barometer"—offering insights into a company's pipeline potential and reflecting how industry veterans gauge the sector’s future.A clear signal of the company’s growth arrived in February 2026, when HighTide Therapeutics (2511.HK) announced a high-profile executive appointment: Dr. Filip Surmont joined the company as Chief Medical Officer (CMO).For professionals in the cardiovascular, renal, and metabolic fields, this is a name that carries real weight. Over a career spanning three decades, Dr. Surmont has held senior medical leadership roles at multinational giants including Wyeth, Pfizer, and AstraZeneca. Among his most notable contributions was his role in the global strategic development of the SGLT-2 inhibitor dapagliflozin — a landmark effort that required close collaboration across functions and geographies within a large multinational organization. As part of a talented cross-functional team, he helped shape the strategy that positioned dapagliflozin as a global metabolic blockbuster, ultimately reaching $8.405 billion USD in sales in 2025.Notably, just a few months earlier, HighTide Therapeutics' core product, HTD1801, had outperformed dapagliflozin across multiple key cardiovascular, renal, and metabolic endpoints in a head-to-head Phase III clinical trial for type 2 diabetes mellitus (T2DM).For Dr. Surmont, transitioning from managing a reigning "blockbuster" to joining a “challenger” Chinese biotech was far from coincidental. What drew him out of his comfort zone was not just HTD1801's strong glucose-lowering performance, but also the breakthrough potential this new molecular entity (NME) has shown in cardiovascular, kidney and metabolic (CKM) disease in general, and chronic kidney disease (CKD) more specifically — driven by a fundamentally differentiated pathophysiological mechanisms.I.Challenging Clinical Complacency in CKD: The Quest for True ReversalWithin the medical community, chronic kidney disease (CKD) has long been a source of frustration. Once the kidney function begins to decline, it typically deteriorates progressively and irreversibly over time, leaving most patients facing dialysis or kidney transplantation as an eventual outcome."There has long been a degree of complacency in CKD treatment among physicians, patients, and even caregivers," Dr. Surmont noted pointedly. "A mindset has taken hold that the progressive decline in renal function with age is inevitable. I’ve been striving to change this mindset throughout my career, both during my time at multinational pharmaceutical companies and now."Current standard treatments — including ACE inhibitors/ARBs and the widely used SGLT-2 inhibitors — have demonstrated efficacy in slowing disease progression, yet fall short of halting or reversing the underlying pathology. They can significantly reduce the rate of decline in the estimated glomerular filtration rate (eGFR), buying patients valuable time, but fail to alter the terminal trajectory towards kidney failure.Further complicating the clinical picture is the multi-factorial nature of CKD. Taking diabetic kidney disease (DKD) caused by T2DM as an example, besides pathophysiological factors driven by metabolic dysfunction, it is complicated by interconnected and highly complex factors such as hemodynamic perturbances, chronic inflammation, fibrosis, and other non-diabetic factors that fuel each other to worsen disease prognosis.Existing standard-of-care drugs often address only one dimension of the disease by regulating hemodynamics or a single metabolic pathway, making it difficult to comprehensively address the inflammatory damage in the renal microenvironment.II.Inside the Mechanism: Remodeling Renal Architecture via a Dual Metabolic and Anti-inflammatory PathwayThe emergence of HTD1801 provides a new key to breaking this deadlock.As an oral anti-inflammatory and metabolic modulator (AIMM) independently developed by HighTide Therapeutics, HTD1801 demonstrates a unique therapeutic potential at the microscopic level as compared to traditional drugs. Rather than relying on a single mechanism, it takes a "two-pronged" approach by activating AMPK (adenosine monophosphate-activated protein kinase) and inhibiting the NLRP3 inflammasome.Dr. Surmont has full confidence in the scientific logic underpinning this mechanism: "This drug acts simultaneously on two critical levels: beyond blood sugar, it improves overall metabolic efficiency at its source; at the same time, it directly suppresses the underlying chronic inflammation that drives organ damage."Taking a deep dive into its mechanism of action, HTD1801's dual mechanism precisely targets multiple microstructures within the kidney. "This is reflected across different renal compartments," Dr. Surmont explained. "From the filtering glomeruli and the structural interstitium to the reabsorptive tubules, and even podocytes—the vital gatekeepers of the filtration barrier, the dual action of AMPK activation and NLRP3 inhibition has demonstrated stronger-than-expected protective benefits."This mechanistic rationale, spanning from metabolic regulation to organ-level protection, has ultimately been validated by clinical data.At the 2025 American Society of Nephrology (ASN) Annual Meeting, HighTide Therapeutics presented as a late breaker Phase III clinical study data in T2DM patients with mild renal impairment. The results captured the industry's attention: compared with the placebo group, the HTD1801 group demonstrated a significant and sustainable difference in annualized eGFR slope of +9.81 ml/min/1.73 m²/year.In the eyes of nephrologists, a "positive slope" on the eGFR curve is a strong and unique signal, suggesting the possibility of early structural recovery."What we need to do next is confirm that this eGFR repair effect observed in DKD also holds true for CKD patients not driven by diabetes," Dr. Surmont revealed, indicating that relevant clinical studies are already underway, with more detailed data expected to validate this cross-etiology therapeutic potential.III.From "Rescue" to "Prevention": Advancing a Holistic Cardiorenal Metabolic (CKM) MindsetDr. Surmont brings to HighTide Therapeutics more than just clinical expertise; he brings a “game-changing” mentality that transcends a single-drug perspective.Another career-defining milestone for Dr. Surmont was his leadership role in helping reshape global asthma treatment guidelines. Historically, asthma management relied on short-acting bronchodilators for "rescue" only upon exacerbation of symptoms and shortness of breath. Dr. Surmont proposed and validated the "Anti-Inflammatory Reliever (AIR)" strategy a modern asthma management strategy that uses a combination inhaled corticosteroids and a bronchodilator as a reliever — treating both the acute bronchospasm and the underlying airway inflammation with every dose, in contrast to traditional short acting dilator-only relief. This shift ultimately benefited approximately 120 million patients worldwide and reshaped treatment paradigms.Now, facing CKD, he sees the same opportunity for a paradigm-shifting breakthrough.Given HTD1801's strong potential to repair mild renal impairment, future clinical guidelines could reasonably recommend initiating treatments early, when eGFR is still at a relatively high level. By establishing a positive trajectory for renal function recovery early in the disease, there is hope that most patients can completely avoid the looming threat of dialysis.From a health-economics perspective, this would reallocate healthcare spending: shifting funds away from costly late-stage interventions (such as dialysis and heart failure rescue) towards highly cost-effective early treatment, thereby generating substantial healthcare cost savings for society and reducing patients’ financial burden for late-stage interventions.Dr. Surmont also strongly advocates for a holistic management approach to "Cardiovascular-Kidney-Metabolic (CKM)" health. As multifunctional drugs like HTD1801 continue to evolve, he believes physicians will move beyond the single-dimensional therapeutic mindset."My ideal scenario is that all physicians managing cardiovascular, metabolic, renal, hepatic, or even obesity issues would evaluate the patient with a holistic mindset," he says, pointing to the current siloed nature in clinical practice. " As an example eGFR monitoring is not always part of routine cardiological assessment, yet at the mechanistic level, cardiac and renal dysfunction are manifestations of the same underlying disease process — making an integrated view essential"He cited a successful experiment he led while promoting dapagliflozin in China: requiring cardiologists at partner hospitals to measure patients' eGFR during their consultations. By merely adding this simple cross-disciplinary action, the number of patients on guideline directed medical treatment tripled within six months.IV.A Buyer's Lens: The Booming BD Activity in CKD and HighTide Therapeutics’ Confidence in Value CreationAs a core member of the company's leadership team, Dr. Surmont also frequently examines HighTide Therapeutics' position through the lens of capital market and industry dynamics.Over the past two years, the global biopharmaceutical market has seen a surge in business development (BD) activity in the CKD field. In 2025, Roche announced a major collaboration with Zealand Pharma valued at up to $5.3 billion; multinational giants like Novartis, Boehringer Ingelheim, and Novo Nordisk have also been making significant investments to secure premium assets in the metabolic and renal disease space.Dr. Surmont, drawing on his extensive multinational experience, has a clear read on this "land grab" phenomenon: "The core driver is the massive profit potential and rapid growth in this field. Five years ago, the therapeutic arsenal here was relatively limited. Now, with breakthrough blockbusters like GLP-1RAs and SGLT-2i’s, the kidney disease landscape has been reshaped, yet there remains a residual risk is 60–80% of the original event burden.He further elaborated: "Even when patients are treated with four pillars of therapy (ACEi/ARBs, SGLT-2i’s, GLP-1RAs, MRAs), the complex underlying inflammatory mechanisms remain largely unaddressed, still leaving a significant gap in our ability to fully protect the kidney. This creates substantial pricing potential and broad combination therapy prospects for drugs with fundamentally new mechanisms like HTD1801.""Looking back at the history of SGLT-2 inhibitors, it took over a decade from approval to reaching 20%-25% guideline-directed clinical uptake. The slow progress was partly due to a lack of strong medical education and advocacy, and partly because of physicians and patients’ tendency to yield to the disease's natural trajectory."Now, having taken the helm as CMO of HighTide Therapeutics, Dr. Filip Surmont is poised to challenge the status quo and break this complacency with solid clinical data and a new medical narrative. For this drug—born from Chinese innovation with a global ambition—the voyage in the CKM field has only just begun. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

TransNusa Launches New Scheduled Flight Connecting Jakarta With Lombok, Its World Class Surfing Island DestinationJAKARTA, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - TransNusa has announced the launch of a new direct scheduled flight connecting Jakarta and Lombok, further strengthening access to one of Indonesia’s key tourism and regional travel hubs.TransNusa Airlines Group Chief Executive Officer, Datuk Bernard Francis said that the introduction of this new route comes on the back of the airline’s focus to increase and strengthen connectivity while boosting domestic tourism.“Lombok is not only rapidly growing as a domestic and international tourist destination but the island is also the main gateway for tourism in the West Nusa Tenggara region through its Lombok International Airport,” Datuk Francis said, adding that Lombok attracts more than 1.2 million tourists annually.LOMBOK… Paradise of divers and surfersLombok is home to the diving haven Gili and Mount Rinjani National Park, one of Indonesia’s most iconic volcanic landscapes. The island offers dramatic trekking routes, cascading waterfalls and panoramic mountain views, attracting adventurers and nature lovers from around the world. Beyond its mountains, Lombok has also built a global reputation as a world-class surfing and diving destination, with pristine beaches, coral reef and consistent waves drawing surfers year-round.“TransNusa will initially operate 14 flights a week or two daily flights with the first scheduled flight departing Jakarta in the morning and the second in the afternoon,” Datuk Bernard said, adding that the sales of tickets for the new scheduled flight from Jakarta to Lombok started on 16 March 2026, with the inaugural flight scheduled for April 17, 2026.DATUK BERNARD FRANCIS… Lombok is the main gateway for tourism in the West Nusa Tenggara regionIn addition to this new launch, TransNusa has also increased the frequency of its Jakarta-Yogyakarta route with the aim to enhance and strengthen domestic connectivity, said Datuk Bernard.Flight DetailsTransNusa’s scheduled flight 8B 5161 will depart Soekarno–Hatta International Airport at 5:00am and arrive at Lombok International Airport at 8:00am. The returning service, 8B 5162, will depart Lombok International Airport at 8:30am and arrive in Jakarta at the Soekarno–Hatta International Airport at 9:30am. The second scheduled flight 8B 5165 will depart Jakarta’s Soekarno–Hatta International Airport at 03:00pm and arrive at the Lombok International Airport at 05:45pm. The returning service, 8B 5166 will depart Lombok International Airport at 06.15pm and arrive at the Soekarno–Hatta International Airport at 06.45pm.Ticket prices for TransNusa’s scheduled Jakarta-Lombok route start from as low as IDR899,000, CNY390, USD55, MYR225, AUD80, and SGD69. Tickets will be available for purchase at www.transnusa.co.id and on primary online travel agents’ platforms.Meanwhile, TransNusa’s additional scheduled flight for its Jakarta-Yogyakarta flight, 8B 5530, will depart Jakarta’s Soekarno–Hatta International Airport at 10.40am and arrive at the Yogyakarta International Airport at 11.50am. The flight, 8B 5531, will depart Yogyakarta at 01.20pm and arrive in Jakarta at 02.30pm.For its flights, TransNusa not only provides premium services with competitive ticket prices, but the airline also has attractive product bundles called SEAT, SEAT-PLUS and FLEXI-PRO."Our SEAT passengers will enjoy check-in baggage of up to 20kgs,” Datuk Bernard said, explaining that the baggage offering was over and above the 7kgs limit offered as a passenger’s hand carry.For the highest package, FLEXI-PRO, we provide services such as free baggage up to 30kgs, free to choose seats, free food, and drinks, priority at check-in and boarding counters.In addition, TransNusa also provides its FLEXI-PRO passengers with the flexibility to change their flight schedule without restrictions and obtain refund when needed,” added Datuk Bernard.TransNusa, which aims to ensure its passengers travel with ease and comfort, has also configured their A320s with a 174-seat configuration, which allows for passengers to enjoy about 30 inches of legroom, comparable to the experience passengers would get in a full-service airline."We are committed to providing affordable and competitive ticket prices, while still providing premium services to our customers.” stressed Datuk Bernard.TransNusa, A Short HistoryThe 3-year old TransNusa, led by aviation expert and veteran, Datuk Bernard, made waves in the aviation industry with its unique domestic and international business development and growth strategy.Within just 6 months of operations, in 2023, the airline, known then as a new player with new rules, launched its first international route between Jakarta and Kuala Lumpur, followed by the launch of scheduled flights between Jakarta and Singapore.TransNusa, which established itself as a Premium Service Carrier, made headlines in Malaysia, Singapore, China and around the world with news of being the first airline in Indonesia to introduce new exciting routes. In 2023, during its first year of operations, TransNusa became the second Indonesian airline to receive approval to fly to China. In 2024, TransNusa became the first in the world to develop and introduce a new domestic route connecting Bali and Manado. In October 2025, TransNusa added yet another milestones by becoming the first Indonesian airline and second airline in the world to launch scheduled flights from Manado to Guangzhou, China.About TransNusaTransNusa Airline, is a Premium Service Carrier. In February 2024, the airline rebranded itself to a Premium Service Carrier in line with its upgraded aircrafts that offers better comfort as well as based on the flexibility and quality of the services offered. TransNusa, which received its AOC certification on 9th September 2022, launch its first three A320 operations on 6th October, 14th October and 12th December, 2022.In 2023, TransNusa introduced a new business model making it the first Premium Service Carrier in the Asia Pacific region. TransNusa introduced its first international flight on 14th April, 2023. The airline is currently based in Jakarta and Bali.On the international front, TransNusa flies to Singapore, Guangzhou, Kuala Lumpur, Perth, Shanghai, and Shenzhen. The airline became the second Indonesian airline to fly to China and the first Indonesian airline to launch a Premium Service Carrier business model. Passengers can book their flights on the TransNusa website at www.transnusa.co.id, through any secure online travel agent, through authorized travel agents in Singapore and Indonesia.TransNusa’s Primary International Media Contact:Trina Thomas Rajtrina@myqaseh.org+60124992672 (whatsapp only) Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - Shoucheng Holdings’ (0697.HK) investments in the robotics sector are moving from early-stage positioning toward value realization.Management has disclosed that, by the end of 2025, the Company—through multiple industry funds under its management—had cumulatively invested more than RMB 2 billion across the broader robotics industry chain, covering more than 20 companies. According to the Chairman’s Statement for 2025, the valuation of the investment portfolio of the Beijing Robot Industry Development Investment Fund (Limited Partnership) increased by approximately fourfold. On that basis, the corresponding unrealized book gain is estimated at around RMB 8 billion. The robotics business has therefore become one of the most closely watched sources of incremental upside for Shoucheng Holdings in the near term.Based on disclosed projects, Shoucheng Holdings’ robotics strategy is not a series of isolated bets, but rather a systematic deployment across the industry chain. In the field of embodied intelligence and robotics, the Company has made concentrated investments in more than 20 leading companies, including Unitree Robotics, Noetix Robotics, Galbot, DEEP Robotics, Booster Robotics, and Galaxea AI. In the latest Chairman’s Statement, Chairman Zhao Tianyang characterized this approach as “track-level deployment”.Unlike some purely financial investors, Shoucheng Holdings is advancing its robotics business from simply “holding equity stakes” to “operating an industry”. Following an integrated path of “investment + operations + ecosystem,” the Company is building capabilities centered on “funds + scenarios + industry chain,” providing robotics companies with capital support, application scenarios, supply-chain integration, and commercialization pathways. On the offline channel side, its robotics consumer experience brand, Taozhu New Creation, has established five stores in Beijing, with locations including Shougang Park, Beijing Capital International Airport Terminals 2 and 3, and Wangfujing APM, among other core venues. To date, the Company has signed agreements with nearly 100 robotics companies as authorized agents.Market analysts note that the valuation logic for Shoucheng Holdings’ robotics business is transitioning from book valuations in the primary market toward more observable pricing in the capital markets. As a representative investment within Shoucheng Holdings’ robotics portfolio, Unitree Robotics—together with its IPO progress—provides the market with a clearer anchor for assessing the value of Shoucheng Holdings’ robotics assets.From a longer-term perspective, the data points of “more than RMB 2 billion invested, more than 20 companies covered, and portfolio valuation increasing approximately fourfold to around RMB 8 billion” already outline the basic contours of Shoucheng Holdings’ robotics strategy:At the front end, the Company secures leading projects through its funds.In the mid-stage, it accelerates commercialization through channels and service systems.At the back end, it opens up exit and re-rating opportunities through IPOs and capital operations.As projects such as Unitree Robotics move into the capital-market spotlight, the book value of Shoucheng Holdings’ robotics investments, its industrial synergy capabilities, and its subsequent monetization path are becoming increasingly clear. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

PHILADELPHIA, PA AND WILMINGTON, DE, Apr 2, 2026 - (ACN Newswire via SeaPRwire.com) - Datavault AI Inc. (NASDAQ:DVLT), an AI-driven data monetization, RWA tokenization, and Web 3.0 infrastructure company, and Demora Foundation, the Delaware-incorporated governing organization of the Demora Chain ecosystem (governed under JP3E Holdings Inc.), today announced the execution of a Technology Integration Agreement establishing Datavault AI as the formal AI data intelligence and RWA tokenization technology partner for the K-Entertainment & K-Wave Global Platform - the integrated K2Global + Demora Foundation ecosystem that converts Korean cultural IP, live entertainment, and K-Wave soft power into institutional-grade, on-chain financial products, deployed across three US Innovation K-Wave Cities: Atlanta (GA), Dallas (TX), and New York Tri-State.K-WAVE AUDIENCE SCALE200M+Global Hallyu Fans · 156 Countries$40B+K-Wave Annual Economic Impact (KOFICE 2024)$14B+K-Pop Revenue 2025E (Live + Streaming + Merch)120M+Dedicated K-Pop Concert Fans Globally500+Korean SMBs · 8 K-Wave Sectors · K2Global Mandate$3B+K-Entertainment Tokenizable Pipeline (DMR-LIVE)3US Innovation K-Wave Cities (ATL · DAL · NY Tri-State)8-14%Target DMR-LIVE Token Yield (Annualized)The Agreement deploys Datavault AI's full enterprise AI stack - Data Vault®, DataValue®, DataScore®, and Information Data Exchange® (IDE) Digital Twin - as the AI data intelligence and RWA/VWA tokenization backbone of Demora Chain, purpose-built to score, value, credentialize, and tokenize K-Entertainment assets - including K-Pop concert revenues, K-Drama IP royalties, K-content digital rights, K-Beauty brands, and K-Food franchises - as yield-bearing instruments settled in DMR (apex RWA) and GMMT (VWA layer) on Demora's dual OP Stack Layer 2.The K-Entertainment Opportunity - 200M+ Fans, $11B-$16B Annual Event Revenue, $3B+ Tokenizable PipelineThe Korean Wave (Hallyu) is the most scalable cultural export engine in the world - and the foundational demand signal for the entire DVLT × Demora Foundation partnership. With 200M+ Hallyu fans across 156 countries generating over $40B in annual economic impact, K-Entertainment represents an institutional-scale, pre-qualified audience base no other RWA protocol can access.K-Entertainment Audience & Tokenizable Pipeline - By VerticalK-Wave VerticalGlobal Fan BaseAnnual Event Revenue Est.Digital / Streaming LayerDMR-LIVE Tokenization OpportunityK-Pop Live Concerts & Tours120M+ dedicated fans$6B - $8B globallyWeverse, YouTube, streaming rights$1.5B+ addressableK-Drama & Film IP Events80M+ drama viewers$2B - $3B IP + premiere circuitNetflix, Disney+, local OTT licensing$600M+ addressableK-Food & Culinary Festivals50M+ global K-Food consumers$800M - $1.2B festivals/franchiseExport brands, franchise licensing$250M+ addressableK-Beauty Brand Events & Launches60M+ active K-Beauty consumers$1B - $1.5B experiential marketingD2C, influencer, brand collab$300M+ addressableGaming, Esports & Webtoon Festivals40M+ K-gaming & esports fans$1.2B - $2B event + IPStreaming, IP licensing, game merch$400M+ addressableTOTAL K-Entertainment TAM200M+ Hallyu Fans (composite)$11B - $16B annual event revenue$5B+ digital overlay$3B+ tokenizable pipelineDMR-LIVE Protocol - K-Entertainment RWA Tokenization EngineAt the core of the DVLT × Demora Foundation partnership is DMR-LIVE - the K-Entertainment RWA tokenization protocol that converts live event cash flows (ticket receivables, venue revenues, VIP hospitality, IP/sponsorship contracts) into yield-bearing digital assets settled on Demora Chain. Datavault AI provides the AI data intelligence layer that makes DMR-LIVE institutional-grade.DMR-LIVE - Projected Deployment & Deal ScalePhase 1 · 0-6 MonthsPilot Launch5-10 K-Wave flagship events (US + Korea)DMR-LIVE token launch on Demora Chain$25M - $50M initial pool issuance500K - 1M live attendeesInstitutional LP onboarding (Reg D)Phase 2 · 6-18 MonthsScale & Liquidity20-40 multi-genre eventsUS, Korea, Africa, SE Asia$100M - $300M issuance target3M - 8M live + digital viewersSWF / Ex-Im institutional channelPhase 3 · 18-36 MonthsGlobal Integration100+ events per annual cycleGlobal deployment (20+ countries)$300M+ annual issuance run-rate15M - 30M annual audienceNASDAQ SPAC pathway for K2GlobalDatavault AI - Powering K-Entertainment IP Intelligence & TokenizationDatavault AI's enterprise platform serves as the data intelligence layer that transforms K-Entertainment assets from illiquid cultural IP into institutional-grade, on-chain financial products:K-Pop & Content IP - IDE Digital Twin & NIL CredentialingOn-chain digital twin representations of K-Pop artist brands, K-Drama IP rights, digital content royalties, and NIL (Name, Image, Likeness) credentials - enabling programmable IP monetization and VWA issuance on GMMT layer.K-Entertainment Asset Valuation - DataScore® AI AgentsAI-based scoring and valuation of K-Pop artist tour revenue forecasts, K-Drama IP licensing streams, K-content streaming rights, and live event cash flow projections - providing the institutional-grade data oracle powering DMR-LIVE token pricing.Franchise & Brand Asset Scoring - DataValue®Comprehensive valuation scoring for K-Beauty brands, K-Food franchise systems, and K-Fashion design IP - preparing these assets for DMR-denominated RWA tokenization and cross-border distribution settlement on Demora Chain.Entertainment & Sports Vertical - HPC Software LicensingHigh-performance compute infrastructure for real-time K-Wave asset valuation, streaming rights scoring, and DMR-denominated tokenization at institutional scale - spanning K-Pop, K-Drama, K-Gaming, and K-Esports verticals.Provenance & Compliance - Data Vault® + Web 3.0 Immutable MetadataEnterprise data management and immutable provenance framework for K-Entertainment IP registrations, royalty flow traceability, and institutional-grade KYC/AML compliance aligned with Demora Chain's DMR settlement requirements.Global Digital Infrastructure Platform - Three-Layer ArchitectureThe DVLT partnership operates across the three-layer JP3E platform architecture - with K-Entertainment as the lead vertical:Platform LayerRole & DVLT Integration PointK2Global (Layer 3 - Application)Asset origination layer: 500+ Korean SMBs across 8 K-Wave sectors. K-Entertainment leads - K-Pop concert IP, K-Drama rights, K-Beauty brands, K-Food franchises. K2Global identifies the real-world and IP assets that DVLT's DataScore® and IDE Digital Twin will score, value, and credentialize for tokenization on Demora Chain.JP3E Holdings (Structure & Access)Institutional governance and capital structure layer. Structures regulatory compliance (Clean Wall separation), OTC → NASDAQ pathway, and sovereign capital access. DVLT's KYC/AML-compliant Web3 data management integrates at this governance layer.Demora Foundation (Layer 1 - Tokenize & Liquidate)Converts illiquid K-Entertainment and K-Wave infrastructure assets into tradable DMR-denominated RWA and GMMT-powered VWA instruments via Demora Chain's dual OP Stack Layer 2. DVLT's HPC-powered tokenization platform and immutable metadata framework are the core technology input at this layer - enabling LP waterfall yield + DMR token upside.K-Wave Cities Deployment - DVLT Integration by SectorThe Technology Integration Agreement positions Datavault AI as the enterprise data intelligence and tokenization technology partner across all eight K-Wave growth sectors in three US Innovation Cities - with K-Entertainment as the flagship commercial vertical:K-Wave SectorDVLT Platform ApplicationEntertainment - K-Pop, Drama IP, Digital Content & MediaFLAGSHIP VERTICAL - IDE Digital Twin & NIL credentialing for K-Pop artist IP, K-Drama content rights, and digital royalty tokenization as VWA on GMMT; DataScore® for AI-based content asset valuation and live event revenue forecasting; DMR-LIVE protocol integration for K-Pop concert receivables tokenization as RWA on DMRFood & Beverage - K-Food Franchise, Cuisine & ExportDataValue® for franchise system and supply chain asset scoring; J1Manna DMR RWA settlement for cross-border distribution contracts through Innovation City hubsBeauty & Cosmetics - K-Beauty Brands, Skincare & BiotechDVLT healthcare HPC licensing applied to K-Beauty O-Min, biotech supply chains; IDE Digital Twin for K-Longevity (NovocellBio NK cell) clinical supply RWA tokenizationTechnology / AI - IoT, Robotics & BlockchainDataScore® AI agents for KORECEN biometric patent (13 KIPO finger-vein) valuation as RWA; DVLT Web 3.0 enterprise data management for IoT/robotics SMB IP assetsManufacturing - Advanced Materials, EV Components & BatteriesDVLT immutable metadata for critical minerals provenance; IDE Digital Twin for K-Defense, dual-use hardware supply chain traceability on DMRHealthcare / Bio - Pharmaceuticals, Medical Devices & TelehealthDVLT healthcare HPC licensing and DataValue® for NovocellBio NK cell manufacturing capacity and clinical supply agreement tokenization as K-Longevity RWA on DMRFashion - Contemporary Design & Textile InnovationIDE NIL credentialing for brand and design IP; DataScore® for O-Min fashion IP asset valuation as VWA on GMMT; cross-border distribution RWA on DMREducation / EdTech - E-Learning Platforms & Global CertificationDVLT Web 3.0 data management for SaaS-model EdTech platform data assets; DataScore® for certification IP valuation feeding Demora flywheel programmable yield via DMRStatements"Datavault AI was built for exactly this moment - when AI-powered data intelligence meets institutional blockchain infrastructure at a global scale. The K2Global Innovation K-Wave platform, with K-Entertainment as its flagship vertical, represents one of the most compelling real-world asset mandates in the market today: 200M+ Hallyu fans, $14B+ in K-Pop revenue, 500+ Korean SMBs, three US Innovation Cities, and a two-token blockchain architecture built for institutional settlement. Our Data Vault®, DataValue®, DataScore®, and Digital Twin platforms are the intelligence layer that transforms K-Entertainment IP - from K-Pop concert revenues and K-Drama royalties to K-Beauty brands and K-Food franchises - from illiquid cultural assets into scalable, liquid digital financial products. We are proud to be the technology partner of choice for the JP3E platform."- Nathaniel Bradley, CEO, Datavault AI Inc. (NASDAQ: DVLT)"The Datavault AI partnership is a defining moment for the Global Digital Infrastructure Platform - and specifically for DMR-LIVE, our K-Entertainment RWA tokenization protocol. K-Entertainment is not merely one of eight K-Wave sectors; it is the cultural demand engine that drives all of them. With 200M+ Hallyu fans, $40B+ in annual K-Wave economic impact, and a $3B+ tokenizable K-Entertainment pipeline, DVLT's AI-powered data valuation, Digital Twin technology, and enterprise tokenization stack provide precisely the intelligence infrastructure required to convert Korean cultural IP into institutional-grade, on-chain financial products at global scale. Together, we are building the operating system for K-Wave infrastructure finance."- John K. Park, Chairman & CEO, Demora Foundation / JP3E Holdings Inc.About Datavault AI Inc. (NASDAQ: DVLT)Datavault AI Inc. (NASDAQ:DVLT) is an AI-driven data monetization, RWA tokenization, and Web 3.0 infrastructure company headquartered at One Commerce Square, 2005 Market Street, Suite 2400, Philadelphia, PA 19103. DVLT provides enterprise-grade platforms including Information Data Exchange® (Digital Twin / NIL credentialing), Data Vault®, DataValue®, and DataScore® AI agents, and HPC-powered data valuation and secure monetization infrastructure spanning fintech, healthcare, real estate, and sports & entertainment verticals - including the full K-Entertainment sector. CEO: Nathaniel Bradley. Website: www.datavaultsite.comAbout Demora FoundationDemora Foundation is the institutional governance entity of Demora Chain - a dual OP Stack Layer 2 on Ethereum (target: 560,000+ TPS, USD1 gas model) designed for stablecoin finance, RWA tokenization, and VWA (Virtual Wealth Asset) creation at institutional scale. Demora Foundation governs the DMR-LIVE K-Entertainment RWA tokenization protocol as the flagship product of its K2Global Innovation K-Wave Cities deployment. Demora Foundation is incorporated in Delaware and governed under JP3E Holdings Inc. Website: demora.foundationMedia Contacts:John K. Park, Chairman & CEO - JP3E Holdings Inc. / Demora FoundationJohn.park@jp3e.com | www.jp3e.com | demora.foundationAlan Wallace, Head of Public Relations - Datavault AI / marketing@dvlt.aiInvestor ContactEdward Barger, VP, Investor Relations - Datavault AI, ir@dvlt.ai - ebarger@dvlt.aiSOURCE: Datavault AI Inc Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com